CNE100002219
CNE100002219
HEILONGJIANG ZBD PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.08B EUR | 4.12B EUR | 6.66B EUR |
Enterprise Value | 8.18B EUR | 7.2B EUR | 9.76B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | 4.86x | -- | -- |
Price to Sales | 13.39x | 9.83x | 8.6x |
Price to Book | 0.84x | 0.69x | 1.09x |
EV/Revenue | 21.57x | 17.17x | 12.59x |
EV/EBITDA | -6.81x | -- | -- |
Price to FCF (P/FCF) | 4.93x | 11.13x | 160.15x |
EV/FCF | 7.94x | 19.44x | 234.51x |
FCF Yield | 20.29% | 8.99% | 0.62% |